Equities

JBM (Healthcare) Ltd

JBM (Healthcare) Ltd

Actions
  • Price (HKD)0.92
  • Today's Change0.02 / 2.22%
  • Shares traded230.00k
  • 1 Year change+2.22%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in HKDIncome statement in HKDView more

Year on year JBM (Healthcare) Ltd grew revenues 24.62% from 520.32m to 648.42m while net income improved 128.51% from 57.09m to 130.46m.
Gross margin52.14%
Net profit margin21.16%
Operating margin26.87%
Return on assets9.83%
Return on equity13.34%
Return on investment12.04%
More ▼

Cash flow in HKDView more

In 2024, cash reserves at JBM (Healthcare) Ltd fell by 11.46m. However, the company earned 191.22m from its operations for a Cash Flow Margin of 29.49%. In addition the company generated 8.31m cash from investing, though they paid out 210.72m more in financing than they received.
Cash flow per share0.2079
Price/Cash flow per share4.12
Book value per share1.17
Tangible book value per share0.1586
More ▼

Balance sheet in HKDView more

JBM (Healthcare) Ltd has a Debt to Total Capital ratio of 11.55%, a higher figure than the previous year's 7.84%.
Current ratio1.66
Quick ratio1.25
Total debt/total equity0.1374
Total debt/total capital0.1155
More ▼

Growth rates in HKD

SmartText is unavailable
Div yield(5 year avg)2.13%
Div growth rate (5 year)--
Payout ratio (TTM)48.78%
EPS growth(5 years)20.26
EPS (TTM) vs
TTM 1 year ago
130.87
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.